254 related articles for article (PubMed ID: 37735707)
41. PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses.
Tsubouchi K; Araya J; Kuwano K
Inflamm Regen; 2018; 38():18. PubMed ID: 30386443
[TBL] [Abstract][Full Text] [Related]
42. Idiopathic pulmonary fibrosis: a disorder of epithelial cell dysfunction.
Zoz DF; Lawson WE; Blackwell TS
Am J Med Sci; 2011 Jun; 341(6):435-8. PubMed ID: 21613930
[TBL] [Abstract][Full Text] [Related]
43. DNA-PKcs modulates progenitor cell proliferation and fibroblast senescence in idiopathic pulmonary fibrosis.
Habiel DM; Hohmann MS; Espindola MS; Coelho AL; Jones I; Jones H; Carnibella R; Pinar I; Werdiger F; Hogaboam CM
BMC Pulm Med; 2019 Aug; 19(1):165. PubMed ID: 31464599
[TBL] [Abstract][Full Text] [Related]
44. Translational control of the fibroblast-extracellular matrix association: An application to pulmonary fibrosis.
Nho RS; Polunovsky V
Translation (Austin); 2013; 1(1):e23934. PubMed ID: 26824013
[TBL] [Abstract][Full Text] [Related]
45. Unraveling FOXO3a and USP18 Functions in Idiopathic Pulmonary Fibrosis through Single-Cell RNA Sequencing of Mouse and Human Lungs.
Wang B; Pan J; Liu Z
Glob Med Genet; 2023 Dec; 10(4):301-310. PubMed ID: 38025194
[No Abstract] [Full Text] [Related]
46. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1.
Lino Cardenas CL; Henaoui IS; Courcot E; Roderburg C; Cauffiez C; Aubert S; Copin MC; Wallaert B; Glowacki F; Dewaeles E; Milosevic J; Maurizio J; Tedrow J; Marcet B; Lo-Guidice JM; Kaminski N; Barbry P; Luedde T; Perrais M; Mari B; Pottier N
PLoS Genet; 2013; 9(2):e1003291. PubMed ID: 23459460
[TBL] [Abstract][Full Text] [Related]
47. A narrative review of the role of HDAC6 in idiopathic pulmonary fibrosis.
Yu H; Liu S; Wang S; Gu X
J Thorac Dis; 2024 Jan; 16(1):688-695. PubMed ID: 38410580
[TBL] [Abstract][Full Text] [Related]
48. Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis.
Cárdenes N; Álvarez D; Sellarés J; Peng Y; Corey C; Wecht S; Nouraie SM; Shanker S; Sembrat J; Bueno M; Shiva S; Mora AL; Rojas M
Stem Cell Res Ther; 2018 Sep; 9(1):257. PubMed ID: 30257725
[TBL] [Abstract][Full Text] [Related]
49. Regulation of the IGF1 signaling pathway is involved in idiopathic pulmonary fibrosis induced by alveolar epithelial cell senescence and core fucosylation.
Sun W; Jing X; Yang X; Huang H; Luo Q; Xia S; Wang P; Wang N; Zhang Q; Guo J; Xu Z
Aging (Albany NY); 2021 Jul; 13(14):18852-18869. PubMed ID: 34329195
[TBL] [Abstract][Full Text] [Related]
50. TRIB3 Mediates Fibroblast Activation and Fibrosis though Interaction with ATF4 in IPF.
Wang L; Zhao W; Xia C; Li Z; Zhao W; Xu K; Wang N; Lian H; Rosas IO; Yu G
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555349
[TBL] [Abstract][Full Text] [Related]
51. tPA promotes the proliferation of lung fibroblasts and activates the Wnt/β-catenin signaling pathway in idiopathic pulmonary fibrosis.
Chen L; Hou J; Fu X; Chen X; Wu J; Han X
Cell Cycle; 2019 Nov; 18(22):3137-3146. PubMed ID: 31550972
[TBL] [Abstract][Full Text] [Related]
52. A Tale of Two Proteolytic Machines: Matrix Metalloproteinases and the Ubiquitin-Proteasome System in Pulmonary Fibrosis.
Roque W; Boni A; Martinez-Manzano J; Romero F
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485920
[TBL] [Abstract][Full Text] [Related]
53. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
54. Fibroblast Senescence in Idiopathic Pulmonary Fibrosis.
Lin Y; Xu Z
Front Cell Dev Biol; 2020; 8():593283. PubMed ID: 33324646
[TBL] [Abstract][Full Text] [Related]
55. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
Wollin L; Wex E; Pautsch A; Schnapp G; Hostettler KE; Stowasser S; Kolb M
Eur Respir J; 2015 May; 45(5):1434-45. PubMed ID: 25745043
[TBL] [Abstract][Full Text] [Related]
56. Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway.
Pei X; Zheng F; Li Y; Lin Z; Han X; Feng Y; Tian Z; Ren D; Cao K; Li C
Cells; 2022 Jan; 11(3):. PubMed ID: 35159160
[TBL] [Abstract][Full Text] [Related]
57. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema.
Chilosi M; Carloni A; Rossi A; Poletti V
Transl Res; 2013 Sep; 162(3):156-73. PubMed ID: 23831269
[TBL] [Abstract][Full Text] [Related]
58. Loss of ANT1 Increases Fibrosis and Epithelial Cell Senescence in Idiopathic Pulmonary Fibrosis.
Sui J; Boatz JC; Shi J; Hu Q; Li X; Zhang Y; Königshoff M; Kliment CR
Am J Respir Cell Mol Biol; 2023 Nov; 69(5):556-569. PubMed ID: 37487137
[TBL] [Abstract][Full Text] [Related]
59. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
[TBL] [Abstract][Full Text] [Related]
60. Inflammation and immunity in IPF pathogenesis and treatment.
Heukels P; Moor CC; von der Thüsen JH; Wijsenbeek MS; Kool M
Respir Med; 2019 Feb; 147():79-91. PubMed ID: 30704705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
